Nutex Health
NUTX
153 hedge funds and large institutions have $502M invested in Nutex Health in 2026 Q2 according to their latest regulatory filings, with 37 funds opening new positions, 63 increasing their positions, 35 reducing their positions, and 12 closing their positions.
208% more first-time investments, than exits
New positions opened: 37 | Existing positions closed: 12
80% more repeat investments, than reductions
Existing positions increased: 63 | Existing positions reduced: 35
41% more capital inflows, than outflows
Capital inflows: $67.2M | Capital outflows: $47.7M
18% more funds holding
Funds holding: 130 → 153 (+23)
2.42% more ownership
Funds ownership: 40.27% → 42.69% (+2.4%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
D.E. Shaw & Co
New York
|
+$12.3M |
| 2 |
Pertento Partners
London,
United Kingdom
|
+$9.8M |
| 3 |
Focus Partners Wealth
Boston,
Massachusetts
|
+$7.71M |
| 4 |
American Century Companies
Kansas City,
Missouri
|
+$4.3M |
| 5 |
Bridgeway Capital Management
Houston,
Texas
|
+$4.04M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCM
Topline Capital Management
Santa Monica,
California
|
-$17.2M |
| 2 |
Millennium Management
New York
|
-$4.75M |
| 3 |
Morgan Stanley
New York
|
-$2.92M |
| 4 |
Trexquant Investment
Stamford,
Connecticut
|
-$2.64M |
| 5 |
DWM
Drive Wealth Management
Lehi,
Utah
|
-$2.22M |
NUTX Hedge Fund Activity: Q2 2026 in Review
153 of the 8,358 institutional investors tracked by Wall St. Rank reported a position in Nutex Health (NUTX) for Q2 2026, worth a combined $502M — up 88% from $267M a quarter earlier.
Buyers outnumbered sellers: 37 funds opened new NUTX positions and 12 closed out — a net gain of 25 holders — while 63 added to existing stakes and 35 trimmed.
The largest buyer was D.E. Shaw & Co, opening a new position worth an estimated $12.3M. The largest seller was Topline Capital Management, cutting an estimated $17.2M.
- 153 institutional investors held Nutex Health (NUTX) as of Q2 2026, up from 130 in Q1 2026.
- Funds reported $502M of Nutex Health stock for Q2 2026, up 88% quarter-over-quarter.
- 37 funds opened new Nutex Health positions in Q2 2026 and 12 closed out, a net change of +25 holders.
- The largest Nutex Health buyer in Q2 2026 was D.E. Shaw & Co, an estimated $12.3M added.
- The largest Nutex Health seller in Q2 2026 was Topline Capital Management, an estimated $17.2M sold.
Based on aggregated 13F filings for Q2 2026.